Evidence map›Paper›PMID 38455253›Full record

ArticleWorld neurosurgery: X2024

Demographics aspects of brain and spine metastatic melanoma. Retrospective analysis in a single third-level center.

Daniel Alejandro Vega-Moreno, Shunichiro Kuramitsu, Eguchi Kaoru, Kajita Yasukazu, Ulises García-González, Abraham Ibarra-de la Torre, Liliana Hernández-Hernández, Rosa María Vicuña-González, Martha Elena González-Jiménez

Open access · goldAbstract read
In one paragraph

Article in World neurosurgery: X, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Daniel Alejandro Vega-MorenoNeurosurgery and Patology Department, Hospital Central Sur de Alta Especialidad, "PEMEX", Mexico City, Mexico.
Shunichiro KuramitsuNeurosurgery Department, Nagoya Medical Center, National Hospital Organization, Aichi, Nagoya, Japan.
Eguchi KaoruNeurosurgery Department, Nagoya Medical Center, National Hospital Organization, Aichi, Nagoya, Japan.
Kajita YasukazuNeurosurgery Department, Nagoya Medical Center, National Hospital Organization, Aichi, Nagoya, Japan.
Ulises García-GonzálezNeurosurgery and Patology Department, Hospital Central Sur de Alta Especialidad, "PEMEX", Mexico City, Mexico.
Abraham Ibarra-de la TorreNeurosurgery and Patology Department, Hospital Central Sur de Alta Especialidad, "PEMEX", Mexico City, Mexico.
Liliana Hernández-HernándezNeurosurgery and Patology Department, Hospital Central Sur de Alta Especialidad, "PEMEX", Mexico City, Mexico.
Rosa María Vicuña-GonzálezNeurosurgery and Patology Department, Hospital Central Sur de Alta Especialidad, "PEMEX", Mexico City, Mexico.
Martha Elena González-JiménezGeneral Direction of Epidemiology, Secretaría de Salud, Mexico City, Mexico.
Pemex (Mexico) · MXNational Hospital Organization · JPSecretaria de Salud · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Melanoma metastases to the CNS rank third in frequency, just after lung and breast metastases. There is controversy regarding the factors predisposing to developing CNS metastases in patients with cutaneous melanoma and their survival with conventional treatments. Methods: We carried out a retrospective analysis in a third-level hospital in Mexico to determine epidemiological aspects of melanoma metastases to the central nervous system, factors related to its appearance, clinical presentation, and survival in three treatment groups: surgery, radiotherapy, and conservative management. Results: We found that the nodular variant has the most significant association with CNS metastases. In addition, the superficial spreading variant has the highest risk of presenting a more substantial number of lesions, up to seven for each case and predominantly in the infratentorial space. On the other hand, we found more remarkable survival in patients treated only with surgery than those treated with radiotherapy or conservatively. Conclusions: This study lays the foundations for future prospective survival analysis of the different current treatment modalities for metastatic melanoma in the brain and spine. It also highlights the clinical risk factors for metastatic brain and spine tumors of melanoma.

Indexed as

Brain melanoma metastasisCentral nervous systemMelanoma metastaticSpine melanoma metastasis

Identifiers

PMID38455253
PMCPMC10918258
OpenAlexW4392142324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.